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Abstract 
Background: Cotrimoxazole (CTX) prophylaxis, recommended in HIV-exposed uninfected (HEU) children primarily 
against HIV-related opportunistic infections, has been shown to have some efficacy against Plasmodium falciparum 
malaria. The effects of CTX prophylaxis on the acquisition of P. falciparum antigen specific CD4+ T cells-mediated 
immunity in HEU children is still not fully understood.
Methods: Peripheral blood was collected from HEU and HIV-unexposed uninfected (HUU) children at 6, 12 and 
18 months of age. Proportion of CD4+ T cells subsets were determined by immunophenotyping. P. falciparum 
antigen-specific CD4+ T cells responses were measured by intracellular cytokine staining assay.
Results: There were no differences in the proportions of naïve, effector and memory CD4+ T cell subsets between 
HEU and HUU children at all ages. There was a trend showing acquisition of P. falciparum-specific IFN-γ and TNF-
producing CD4+ T cells with age in both HUU and HEU children. There was, however, lower frequency of P. falciparum-
specific IFN-γ-producing CD4+ T cells in HEU compared to HUU at 6 and 12 months, which normalized 6 months after 
stopping CTX prophylaxis.
Conclusion: The results demonstrate that there is delayed acquisition of P. falciparum-specific IFN-γ-producing CD4+ 
T cells in HEU children on daily cotrimoxazole prophylaxis, which is evident at 6 and 12 months of age in comparison 
to HUU age-matched controls. However, whether this delayed acquisition of P. falciparum-specific IFN-γ-producing 
CD4+ T cells leads to higher risk to malaria disease remains unknown and warrants further investigation.
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Background
In children, repeated exposure to Plasmodium falci-
parum antigens contributes towards the development 
of effective immunity that controls parasitaemia and 
prevents severe and life threatening illness [1, 2]. Evi-
dence from mouse models and experimental human 
infections suggests that both CD4+ and CD8+ T cells play 
an important role in protective immunity to P. falciparum 
malaria [3–6]. T cells directly control the development 
of pre-erythrocytic Plasmodium stages and also direct 
the immune responses induced by erythrocytic stages 
of malaria [7]. During blood stage infection, acute pro-
inflammatory cytokine-mediated effector responses from 
CD4+ T cells can restrict growth of the malaria parasites 
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and reduce risk of clinical disease [7]. Of note, produc-
tion of IFN-γ, TNF, IL-2, IL-6 and IL-4 has been shown in 
various ways to play a role in anti-malarial immunity [6, 
8–13]. IFN-γ has been proposed as the major mediator of 
parasite clearance during blood stage infection [14].
Continuous malaria chemoprophylaxis has been shown 
to slow down the development of clinical immunity in 
children leading to an increased risk of disease follow-
ing disruption or cessation of treatment [15, 16]. Cot-
rimoxazole (CTX), a potent antibiotic and with strong 
anti-malarial properties [17], is recommended for proph-
ylaxis in HIV exposed uninfected (HEU) children in the 
first 12 months of age, primarily to prevent HIV-related 
opportunistic infections. Due to its anti-malarial proper-
ties, CTX may potentially confer malaria chemoprophy-
laxis, preventing the natural exposure to P. falciparum 
and subsequent acquisition of malaria specific immunity.
Although there is now good evidence to show that 
CTX prevents clinical malaria in children taking it [17, 
18], limited data exist on the impact of CTX exposure on 
development of clinical immunity to malaria following 
cessation of prophylaxis. Immunological measurements 
against malaria antigens may provide a useful approach 
to monitor development of natural immunity to malaria 
during and following termination of CTX prophylaxis. Of 
the few studies that have looked at the effect of malaria 
chemoprophylaxis on both humoral and cellular immune 
responses during and post prophylaxis, the results have 
been somehow contradictory with children who had 
received chemoprophylaxis showing reduced levels of 
malaria specific antibodies but increased cell medi-
ated immunity [19, 20]. Contrary to studies by Aponte 
et al. [15] and Menendez et al. [16], these earlier studies 
[19, 20] showed no lasting impairment of the protective 
immunity as measured by incidence of clinical disease in 
the year following cessation of chemoprophylaxis indi-
cating that perhaps cell mediated immunity is protective 
despite lower antibody response.
Since CTX is given to these HEU children primarily as 
an antibiotic rather malaria chemoprophylaxis, its impact 
on development of natural immunity to malaria in HEU 
children needs careful assessment. HEU Malawian chil-
dren on CTX prophylaxis have reduced magnitude and 
breadth of IgG antibody responses to distinct P. falcipa-
rum merozoite antigens [21] indicating a lack of expo-
sure to malaria antigens. Given the importance of T cell 
mediated immunity to malaria and that T cell response to 
malaria antigens correlates poorly with humoral immune 
responses [19, 22], this study investigated the effects 
of CTX prophylaxis on the magnitude of P. falciparum 
antigen specific CD4+ T cells in HEU children during 
and after prophylaxis, and compared with aged-matched 
HIV-unexposed uninfected (HUU) children.
Methods
Study population
Characteristics of the study area, design and partici-
pants have already been described in detail before [21]. 
Briefly, the study was conducted in Zomba district, 
Malawi where P. falciparum malaria transmission is sta-
ble throughout the year, with P. falciparum prevalence 
rate of around 27  % [23]. HEU children were recruited 
from the ART clinic at the Zomba Central Hospital and 
aged matched HUU children as controls from the com-
munities where HEU children were based. Children who 
were classified as healthy at the time of recruitment and 
were not on any medication and were breastfeeding were 
included in the study. As a national policy for Malawi, 
daily CTX prophylaxis is given to all HEU children from 
6  weeks of age, and all pregnant mothers are put on 
antiretroviral therapy (ART). Individual written informed 
consent was obtained from the parents or guardians of all 
children. The College of Medicine Research Ethics Com-
mittee (COMREC) approved this protocol.
Collection and processing of samples
Children were seen every 6 months and at each visit, a total 
of 3 ml of venous blood was collected. 2 ml in sodium hepa-
rin tube for intracellular cytokine assay and 1 ml of in EDTA 
tubes for immunophenotyping. All immunological assays 
were conducted blinded to the children’s study group.
Plasmodium falciparum antigens
Cryopreserved laboratory adopted strain of P. falciparum 
(3D7) was kindly provided by ICMER laboratory, Blan-
tyre, Malawi. For recovery, parasite aliquots were thawed 
using two sodium chloride thawing solutions: (200 µl of 
12 % NaCl and 10 ml of 1.6 % NaCl) and washed twice 
with 25 ml of protein free medium (RPMI-1640 supple-
mented with 25 mmol/l HEPES and 40 mg/ml gentamy-
cin), as described elsewhere [24]. Parasite culture to late 
trophozoite stage was done using standard protocols as 
previously described [25].
Level of parasitaemia was estimated based on micros-
copy of thin smears and parasitaemia level of approxi-
mately 5  % was used. Pooled cultures were washed and 
1.5 ml of warm protein free medium was added to the red 
cell pellet followed by 2.5  ml warm gelofosine (Bbraun, 
Melsungen, Germany). The mixture was then allowed 
to stand for 20  min at 37  °C and supernatant carefully 
removed and transferred to a second tube. The mix-
ture was washed and approximately 1 μl of the pellet was 
collected and parasitaemia determined as previously 
described [25]. The infected erythrocytes were lysed using 
saponin lysis procedure as previously described [26]. Pro-
tein content was determined by NanoDrop as per manu-
facturer’s instructions and the lysate stored at −80 °C.
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Immunophenotyping
Whole blood (20  μl) was stained with surface markers 
(CD3 PE, CD4 PerCP and CD8 APC-H7 (all from BD 
Biosciences, San Jose, CA, USA), CD45RA FITC (BD 
Pharmingen, San Jose, CA, USA) and CCR7 APC (eBio-
sciences, San Diego, California) and lysed with 2  ml of 
1× FACS lysing solution. After wash, the cells were then 
acquired on a Cyan ADP flow cytometer (Beckman Coul-
ter) and minimum of 10,000 lymphocytes events was col-
lected per tube during acquisition.
Intracellular cytokine staining
Heparinized whole blood (100  μl) was cultured in 96 U 
bottom culture plate and incubated with PMA/Iono-
mycin (10  ng/ml and 100  µg/ml, Sigma-Aldrich, UK), 
P. falciparum 3D7 schizonts lysate (5 µg/ml) and myco-
bacterium purified protein derivative (10 µg/ml, Statens 
Serum Institut, Denmark) in parallel with a non-stimu-
lated background control for 24 h. Harvested cells were 
stained with surface markersCD3-APC-H7, CD4-PerCP 
(all from BD Biosciences, San Jose, CA, USA), and CD8-
Pacific Orange (Invitrogen™ Life technologies, Carls-
bad, CA, USA) and lysed as above. The cells were the 
permeabilized with 500  μl of 1× BD Cytofix/Cytoperm 
(BD Cytofix/Cytoperm™, San Diego, California) and 
then stained with intracellular markers IFN-γ-FITC (BD 
FastImmune™, San Jose, CA, USA) and TNF-PE (BD Bio-
sciences, San Jose, California) for 30 min. The cells were 
then acquired as above and minimum of 10,000 CD4+ T 
cell events were collected per sample. Single stained BD 
comp beads were processed and acquired in parallel to 
samples each day and used for compensation. Analysis 
was conducted using FlowJo software version 9.7.5 (Tree 
Star Inc., San Carlos, CA, USA).
Statistical analysis
Statistical analysis and graphical presentation were done 
using GraphPad Prism 6 (GraphPad, California, USA) 
and STATA (StataCorp, Texas, USA). A Shapiro–Wilk 
normality test revealed that all data were non-normally 
distributed. Mann–Whitney U test was used for com-
parison CD4+ T cell proportions and frequencies of 
cytokine producing cells between the study groups at 
each visit. Background responses generated in the nega-
tive control wells were subtracted from responses gener-
ated from antigen-stimulation to obtain antigen-specific 




Overall, 33 HEU children and 31 age and location-matched 
HUU children were recruited in the study and followed 
through from 6 to 18  months of age (Table  1). Both the 
HEU and HUU groups were comparable for both baseline 
and follow up characteristics. All children were afebrile and 
asymptomatic at the time of venous blood draw at each 
visit. The median birth weight was similar between HEU 
and HUU children (3.2 vs. 3 Kg, p = 0.21). All mothers of 
the HEU children were on ART and were taking daily CTX 
prophylaxis during the entire follow up period.
Proportion of CD4+ T cell subsets in HEU and HUU children 
at 6 , 12  and 18 months
Immune phenotypic defects have been previously 
reported in HEU infants, mostly in the pre-ART era 
[28], but it still remains unclear whether this is the 
case during the ART era. This study, therefore, phe-
notypically characterized CD4+ T cell subsets in HEU 
children and HUU aged-matched controls, to inves-
tigate whether HIV exposure and CTX prophylaxis 
alters the population of CD4 T cell subsets in children. 
The expression of CD45RA and CCR7 allowed for the 
characterization of naïve (CD45RA+CCR7+), central 
memory (TCM, CD45RA−CCR7+), effector memory 
(TEM, CD45RA−CCR7−), and terminally differentiated 
(CD45RA+CCR7−) T cells (Fig. 1a). There were no signif-
icant differences in the median proportion of naïve CD4+ 
T cells (Fig. 1b), TCM CD4+T cells (Fig. 2c), TEMCD4+ T 
cells (Fig. 2d) and terminally differentiated CD4+ T cells 
(Fig. 2e) between HEU and HUU children at all ages (6, 
12 and 18 months). These data suggest that HIV exposure 
or probably CTX prophylaxis did not lead to any appar-
ent impairment in the populating of CD4+ T cell subsets 
beyond 6 months of age in HEU children.
Frequencies of total cytokine‑producing Plasmodium 
falciparum antigen specific CD4+ T cells in HEU and HUU 
children
To investigate whether there is delayed acquisition of P. 
falciparum antigen-specific CD4+T cell in HEU during 
CTX prophylaxis, the frequency IFN-γ- and TNF-pro-
ducing CD4+T cells in whole blood following stimula-
tion with antigens was determined (Fig. 2). It was found 
that in both HEU and HUU children there was acquisi-
tion of P. falciparum antigen-specific CD4+T cell with 
age (Fig.  3). Specifically, there was an increase in the 
proportion of responders with age, in both HEU and 
HUU children (Fig. 3a, c). There was also an increase in 
the frequency of P. falciparum antigen-specific CD4+T 
cells with age, in both HEU and HUU children (Fig. 3a, 
c). Interestingly, the frequency of P. falciparum antigen-
specific CD4+T cells was lower in HEU children at 6 
and 12  months in comparison to HUU children, which 
was the period the HEU children were on CTX prophy-
laxis (Fig.  3b, d). Upon CTX prophylaxis cessation, the 
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frequency of P. falciparum antigen-specific CD4+T cells 
in HEU children normalized to levels seen in HUU age-
matched controls (Fig. 3b, d).
Next, it was hypothesized that if the lower frequency 
of P. falciparum antigen-specific CD4+T cells was due 
to generalized effects of CTX prophylaxis, then the 
Table 1 Demographic characteristics of the study participants
p p value, WBC white blood cells, ART antiretroviral therapy, CTX cotrimoxazole
* p value obtained with Mann–Whitney U test, p value of <0.05 was considered significant
a Presented as medians
Descriptiona Age of study participants at each visit
6 months 12 months 18 months
HUU HEU p* HUU HEU p HUU HEU p
Demographic data
Number of children per visit 31 33 – 29 31 – 28 30 –
Females (%) 65 46 – 62 42 – 64 40 –
Laboratory parameters
WBC count, ×103 cells/ml 10.2 9.45 0.51 11.5 12.0 0.65 9.5 8.4 0.34
Total CD4 T cells (%) 58.4 55.2 0.042 51.1 54.8 0.62 48.8 54.8 0.052
Mothers health status
Mother on ART,  % – 97 – – 100 – – 97 –
Mother on CTX,  % – 100 – – 100 – – 100 –
Fig. 1 The proportions of naive and memory CD4+ T cell subsets in HEU and HUU children at different ages. Cells were stained anti CD3 PE, anti 
CD4 PerCP, anti CD8 APC-H7, anti CD45RA FITC and anti CCR7 APC monoclonal antibodies. a A gate was drawn on CD4− CD8−(non T cells) and 
CD4+ CD8− (CD4+ T cells) populations and plotted on CD45RA FITC against CCR7 APC. Using quadrant statistics, distinct populations of naïve 
(CD45RA+ CCR7+), central memory (CD45RA−CCR7+), effector memory (CD45RA− CCR7−), and terminally differentiated (CD45RA+ CCR7−) CD4+ 
T cells were identified. Median proportions of Naïve CD4+ (b), central memory CD4+ (c), effector memory CD4+ (d), and terminally differentiated 
CD4+T lymphocytes (e) were determined in peripheral blood of HEU and HUU children at 6, 12 and 18 months. X-axis represents age of children in 
months. Horizontal bars represent medians
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frequency of mitogen-stimulated and antigen-specific 
CD4+ T cells in HEU children will also be lower than 
HUU age-matched controls. The results show that 
there was no difference in the frequency of mitogen-
stimulated CD4+ T cells and the number of responders 
between HEU children and HUU age-matched controls 
at all ages (Fig.  4). It was also found that the frequency 
of mycobacterium-specific CD4+ T cells was not sig-
nificantly different between HEU children and HUU 
age-matched controls at 12 and 18 months (Fig. 5). This 
suggests that the lower frequency of P. falciparum anti-
gen-specific CD4+ T cells observed in HEU compared to 
HUU children was not generalized, but was specific to P. 
falciparum.
Prevalence of asymptomatic and clinical malaria in HEU 
and HUU children
To determine whether the delayed acquisition of P. fal-
ciparum antigen-specific CD4+ T cells would result in 
higher prevalence of asymptomatic and clinical malaria 
in HEU children. The number of children with asympto-
matic malaria at each scheduled visit was similar in both 
groups; 6 months (HEU 3 vs. HUU 6.5  %), 12  months 
(HEU 6.5 vs. HUU 0 %) and 18 months (HEU 6.7 vs. HUU 
7.1  %). The number of HEU and HUU children with at 
least one episode of clinical malaria at any time of the fol-
low up period was similar between HEU and HUU chil-
dren (9.1 vs. 12.9 %). There was no evidence of increased 
prevalence of asymptomatic and clinical malaria in HEU 
Fig. 2 Representative FACS plots showing gating strategy for identifying antigen specific CD4+ T cell by intracellular cytokine staining assay. Hep-
arinized whole blood collected at 6, 12 and 18 months was stimulated with PMA, P. falciparum 3D7 strain, purified protein derivative (PPD) and no 
antigen for 24 h. Lymphocytes were gated using FSC vs. SSC plots, FSC vs. CD3+ T cells and then CD4+T cells vs. CD8+T cells to isolate CD4+ T cells. 
Non-stimulated control samples were used to establish the threshold quadrants of background responses that were applied to quantify positive 
cytokine-producing cells in paired antigen-stimulated samples
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children on CTX prophylaxis compared to HUU age-
matched controls, but the study was underpowered to 
conclusively determine this clinical endpoint.
Discussion
This study investigated the effect of CTX prophylaxis on 
the acquisition of P. falciparum antigen specific CD4+ T 
cells in HEU children. The study findings demonstrate 
that in the context of unaltered proportions of naïve and 
memory CD4+ T cell subsets and unimpaired CD4+ T 
cell IFN-γ and TNF producing function, the frequency 
of P. falciparum antigen-specific IFN-γ-producing CD4+ 
T cells was lower in HEU children on CTX prophylaxis 
compared to HUU age-matched controls. However, this 
normalized to levels seen in HUU children, 6 months 
upon CTX prophylaxis cessation.
Phenotypic alterations in the proportions of naive and 
memory T cell subsets have been observed in HEU chil-
dren during early life [27, 28]. Consequently, alterations 
in the numbers or proportions of CD4+ T cell subsets 
may affect the capacity of antigen specific CD4+ T cell 
response to infections [29], leading to an increase in risk 
of infections in HEU children [30–32]. In this study, there 
was no difference in proportion of CD4+ T cell subsets in 
between HEU and HUU children from 6   to 18 months 
of age indicating that HEU children have normal CD4+ 
T cell phenotypes, contrary to earlier reports which were 
done mostly during the pre-ART era [28, 33].
The frequencies of P. falciparum antigen-specific IFN-
γ-producing CD4+ T cells in HEU children during the 
period on CTX prophylaxis was lower in comparison to 
HUU age-matched controls. However, there was no dif-
ferences in the mitogen-stimulation or Mycobacterium-
specific CD4+ T cells. IFN-γ plays an important role in 
regulating the protective immune responses against 
blood stage malaria infection even in the absence of anti-
body response [34] and has been shown to be a poten-
tial marker of P. falciparum exposure [35]. Similar lower 
frequencies of P. falciparum specific CD4+ T cells were 
observed in Ugandan under-five children with lower 
prior malaria incidence compared to children with higher 
prior incidence[12]. This observation supports the idea 
Fig. 3 Frequency of PMA/Ionomycin stimulated CD4+ T cells in HEU and HUU children at different ages. a Total percentage of all IFN-γ cytokine 
producing CD4+ T cells was determined in HEU children and compared to HUU children at 6, 12 and 18 months of age. b Histogram comparing 
total percentage of all IFN-γ cytokine producing CD4+ T cells between HEU and HUU children overtime. c Total percentage of all TNF cytokine pro-
ducing CD4+ T cells was determined in HEU children and compared to HUU children at 6, 12 and 18 months of age. d Histogram comparing total 
percentage of all TNF cytokine producing CD4+ T cells between HEU and HUU children overtime. X-axis represents time of visit. Black horizontal bars 
represent (a, c) mean with confidence intervals or (b, d) mean with SEM. Statistical significance was determined if p value was equal to or less than 
0.05
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that CTX prophylaxis reduces natural exposure to P. fal-
ciparum, resulting in a delayed acquisition of cell-medi-
ated immunity against malaria, which ultimately may 
result in impaired development of P. falciparum antigen-
specific antibody-mediated immunity [21].
In contrast to previous results in the same popula-
tion [21], where antibody responses in HEU children 
remained low post-CTX prophylaxis reflecting delayed 
acquisition of antibody responses following CTX proph-
ylaxis, the frequency of P. falciparum antigen-specific 
IFN-γ-producing CD4+ T cells normalized following 
cessation of prophylaxis and were comparable to HUU 
children by 18 months of age. Studies from experimental 
malaria challenge showed that even a single exposure to 
malaria induced robust CD4+ T cell responses producing 
IFN-y that could be detected 14 months post infection in 
the absence of further exposure[6]. These results might 
therefore explain the current observation that showed a 
significant increase in the frequency of IFN-γ producing 
CD4+ T cells in response to P. falciparum in HEU chil-
dren after CTX prophylaxis suggesting different patterns 
in acquisition of humoral and T cell mediated immunity 
to malaria following CTX prophylaxis.
Due to the importance of the IFN-γ in immunity 
against malaria, it would be anticipated that delayed 
acquisition of P. falciparum antigen-specific IFN-γ-
producing CD4+ T cells would lead to increase risk to 
asymptomatic and clinical malaria. Unfortunately, this 
current study could not gather enough clinical endpoints, 
as it was observed that the prevalence of parasitaemia 
and clinical malaria in both HEU and HUU children in 
the study was much lower than the estimated 27 %. This 
underpowered the study to conclusively show any clini-
cal endpoint differences attributed to the CTX induced 
perturbation in P. falciparum-specific immunity between 
the two study groups. Nevertheless, the study reports an 
important observation showing delayed acquisition of P. 
falciparum-specific immunity in HEU children during 
CTX prophylaxis, which requires further investigation.
The choice of immune responses investigated in the 
study is not exhaustive, and the authors acknowledge that 
there are other mechanisms that are equally as important. 
Fig. 4 Frequency of Plasmodium falciparum antigen specific CD4+ T cells in HEU and HUU children at different ages. a Total percentage of all IFN-γ 
cytokine producing CD4+ T cells was determined in HEU children and compared to HUU children at 6, 12 and 18 months of age. b Histogram 
comparing total percentage of all IFN-γ cytokine producing CD4+ T cells between HEU and HUU children overtime. c Total percentage of all TNF 
cytokine producing CD4+ T cells was determined in HEU children and compared to HUU children at 6, 12 and 18 months of age. d Histogram com-
paring total percentage of all TNF cytokine producing CD4+ T cells between HEU and HUU children overtime. X-axis represents time of visit. Black 
horizontal bars represent (a, c) mean with confidence intervals or (b, d) mean with SEM. Statistical significance was determined if p value was equal 
to or less than 0.05
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CD4+ T cells producing other cytokines such IL-2, 
IL-10 and IL-4 alone or in combination with the studied 
cytokines have been shown to be associated with protec-
tion from malaria [6, 8, 11, 12]. However, IFN-γ and TNF 
are among the major cytokines shown to be associated 
with immunity against malaria, hence the study provides 
valid insight on the effect of CTX prophylaxis on anti-
gen-specific CD4+ T cells immune responses. Secondly, 
although CD4+ T cells are an important producer of IFN-
g, they are not the only cells that produce this important 
cytokine since macrophages, NK and B cells [36, 37] are 
also known to be a good source of this cytokine. Further-
more, it would have been ideal to have HEU children 
not on CTX prophylaxis or to have a subgroup of HEU 
children on CTX prophylaxis beyond 12  months, but 
this was deemed unethical and not justifiable within the 
study setting, hence the study had to be done in line with 
the national policy for Malawi that requires daily CTX 
prophylaxis to be given to all HEU children from 6 weeks 
to 12 months of age.
In conclusion, the study has shown that CTX prophy-
laxis is associated with delayed acquisition of P. falci-
parum antigen-specific CD4+ T cells in HEU children. 
This has potential to increase the risk of malaria infec-
tion following cessation of CTX prophylaxis, but this 
study was not able to conclusively address this hypoth-
esis due to limitations in sample size and the duration 
of the follow-up period. Future studies should be based 
on a larger sample size and longer follow up durations 
to ascertain definitively the impact of CTX prophylaxis 
mediated delay in anti-malarial immunity on risk to clini-
cal malaria. This is a public health dilemma that needs to 
be tackled.
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